News/ Rare diseases Marathon sells Duchenne drug to PTC Richard Staines Duchenne muscular dystrophy, M&A, Marathon Pharmaceuticals, orphan, pricing, PTC Therapeutics 0 Comment PTC says it will make changes to the price after abandoned launch last month. Share X Marathon sells Duchenne drug to PTC https://pharmaphorum.com/transversal-categories/rare-diseases/marathon-sells-duchenne-drug-ptc/
News/ Sales and Marketing/ US Marathon halts launch of Duchenne drug after price outcry Andrew McConaghie Bernie Sanders, Duchenne, Marathon Pharmaceuticals, Rare diseases 0 Comment Company says it will listen to concerns of patient advocates Share X Marathon halts launch of Duchenne drug after price outcry https://pharmaphorum.com/news/marathon-halts-launch-duchenne-drug-price-outcry/